Turning Point Benefit Group’s Zoetis ZTS Stock Holding History

Turning Point Benefit Group’s Portfolio ZTS Stock Details ZTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-76	Closed	-$9.56K	–	824
2025 Q4	$9.56K	Buy	+76	New	+$9.91K	0.01%	244

Other funds holding ZTS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Turning Point Benefit Group's ZTS Position: Q1 2026 in Review

Turning Point Benefit Group sold out of Zoetis (ZTS) in Q1 2026, closing a stake of 76 shares — an estimated $9.56K sold.

Turning Point Benefit Group first reported a position in ZTS in Q4 2025 and held it in 1 quarter. The position peaked at $9.56K in Q4 2025. 1,614 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

Turning Point Benefit Group reported no remaining Zoetis position as of Q1 2026 after selling out during the quarter.
Turning Point Benefit Group sold 76 Zoetis shares in Q1 2026, an estimated $9.56K.
Turning Point Benefit Group first reported a position in Zoetis in Q4 2025 and held it in 1 quarter.
Turning Point Benefit Group's Zoetis position peaked at $9.56K in Q4 2025.
1,614 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on Turning Point Benefit Group's 13F filing for Q1 2026, filed 12 May 2026.